Michael Sinclair, CEO, discusses AVO’s light proton therapy system, its advantages and potential to disrupt the radiation oncology market.
Home » Advanced Oncotherapy (AVO) » Advanced Oncotherapy (AVO) – CEO discusses proton beam therapy
Michael Sinclair, CEO, discusses AVO’s light proton therapy system, its advantages and potential to disrupt the radiation oncology market.